While some studies have reported that LRP1B silencing with siRNA/shRNA results in increased proliferation, migration, and invasion in several cancer cell lines [14,18,19], others have shown that lentiviral CRISPR/Cas9 LRP1B knockdown inhibited cell growth in HCC cells [20]. Here, LRP1B is linked to cancer.